Brevundimonas aurantiaca

(aka Caulobacter henricii subsp. aurantiacus)

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Brevundimonas aurantiaca, (aka Caulobacter henricii subsp. aurantiacus), is a Gram-negative, non-spore-forming, aerobic, vibrio bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 67%. Brevundimonas aurantiaca is probably a rare gut coloniser. (Abraham1999; Poindexter1964; Vancanneyt2005Bergey)



  • This organism has been recovered from human faeces. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread. Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Poindexter1964); (Vancanneyt2005Bergey);
    Character Response
  • Substrates hydrolysed or digested:
  • starch;
  • 🧂
  • Salt tolerance:
  • tolerates 2% salt; doesn't tolerate 4% salt; Grows optimally with 0.5-2.0% salt.
  • ⥅
  • Substrates assimilated or utilised:
  • ethanol; galactose; glucose; maltose; starch; sucrose; alanine; D-alanine; aspartate; glutamate; proline; serine; acetate; butyrate; fumarate; lactate; L-malate; pyruvate; succinate; glutamine;
  • Active enzymes:
  • catalase;
    • SPECIAL FEATURES (Poindexter1964); (Vancanneyt2005Bergey);
    Character Response
  • ✗
  • Nitrate:
  • not reduced
  • ±
  • Pigments:
  • dark golden
    • RESPONSE TO ANTIBIOTICS (Poindexter1964);
    Class Active Resistant
  • Penicillins:
  • penicillin;
  • Aminoglycosides:
  • streptomycin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Alphaproteobacteria Order:  Caulobacterales Family:  Caulobacteraceae Genus:  Brevundimonas Alt. name:  Caulobacter henricii subsp. aurantiacus Gram stain:  neg O2 Relation.:  aerobic Spore:  No spore Morphology:  Vibrio Pigment:  dark golden
    Health:  Unknown
    Source:  human faeces
    DNA G+C(%):  67
    NaCl 0.5-2%:  2(+)
    NaCl 3-5%:  4(neg)
    		Starch:  +
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Arabinose:  neg L-Arabinose:  neg Fructose:  neg Galactose:  + Glucose:  + Mannose:  neg Ribose:  neg Xylose:  neg Lactose:  neg Maltose:  + Sucrose:  + Ethanol:  + Methanol:  neg Starch:  + Ala:  + D-Ala:  + Arg:  neg Asp:  + Glu:  + His:  neg Ile:  neg Leu:  neg Lys:  neg Pro:  + Ser:  + Tyr:  neg Val:  neg Acetate:  + Butyrate:  + Fumarate:  + Lactate:  + L-Malate:  + Pyruvate:  + Succinate:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  +
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Pigment:  dark golden
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    penicillin:  S(1000U)
    streptomycin:  S(100)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)

    References

    SPECIFIC REFERENCES FOR BREVUNDIMONAS AURANTIACA
  • Abraham1999 - Phylogeny and polyphasic taxonomy of Caulobacter species. Proposal of Maricaulis gen. nov. with Maricaulis maris (Poindexter) comb. nov. as the type species, and emended description of the genera Brevundimonas and Caulobacter.
  • Poindexter1964 - Biological Properties and Classification of the Caulobacter Group.
  • Vancanneyt2005Bergey - Bergey's manual of systematic bacteriology. Vol. 2, The The Alpha-, Beta-, Delta-, and Epsilonproteobacteria Part C. Family Caulobacteraceae, Genus III. Brevundimonas
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR BREVUNDIMONAS AURANTIACA
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • ...............................
    • Added: December 15, 2021